HK Stock MarketDetailed Quotes
02157 LEPU BIO-B
- 2.890
- -0.120-3.99%
Market Closed Nov 28 16:08 CST
4.94BMarket Cap-61489P/E (TTM)
3.040High2.850Low2.21MVolume3.010Open3.010Pre Close6.46MTurnover0.13%Turnover RatioLossP/E (Static)1.71BShares6.50052wk High4.93P/B4.79BFloat Cap2.16052wk Low--Dividend TTM1.66BShs Float31.800Historical High--Dividend LFY6.31%Amplitude2.160Historical Low2.925Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
About LEPU BIO-B Company
Lepu Biotechnology Co., Ltd. is an innovative biopharmaceutical company based in China and focusing on the field of cancer treatment for the world. We have developed a strong product pipeline focusing on oncolog-focused drug candidates, including clinical and preclinical ADCs, oncolytic virus drugs, and immunotherapy. We plan to commercialize the product pipeline domestically by building a professional sales and marketing team, and promote the product pipeline to overseas markets such as the US and Europe through cooperation with overseas companies.
Company Profile
Symbol02157
Company NameLEPU BIO-B
ISINCNE100004SM4
Listing DateFeb 23, 2022
Issue Price7.13
Shares Offered126.88M share(s)
FoundedJan 19, 2018
Registered AddressChina
Chairmanzhongjie pu
Secretaryshaojuanliyunyi li
Company CategoryOther
Registered Office2nd Floor, Building 41, No. 518, Xinzhuan Road, Songjiang District, Shanghai, China
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees491
MarketHong Kong motherboard
Phone(021)67696099
Websitehttp://www.lepubiopharma.com
Business Lepu Biotech Co., Ltd. is a Chinese biopharmaceutical company focused on the field of oncology treatment. The company mainly develops product pipelines for cancer candidates, including ADCs, oncolytic virus drugs, and immunotherapy in clinical and preclinical stages. The company's main research pipeline assets include MRG003, MRG002, HX008 and LP002, as well as three key clinical phase drug candidates. The company's products are sold to domestic and foreign markets.
Company Executives
- Name
- Position
- Salary
- zhongjie pu
- Chairman, Executive Director, Chairman of the Strategy Committee, Remuneration and Evaluation Committee Member, Nomination Committee Members, Authorized Representative
- --
- ziye sui
- Executive Director, General Manager, Strategy Committee Members
- --
- jue pu
- Non-executive Directors, Audit Committee Members
- --
- hongbing yang
- Non-executive Directors
- --
- demin zhou
- Independent Non-Executive Director, Chairman of the Nomination Committee, Strategy Committee Members
- --
- haifeng yang
- Independent Non-Executive Director, Chairman of the Remuneration and Evaluation Committee, Audit Committee Members, Nomination Committee Members
- --
- fengmao hua
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration and Evaluation Committee Member
- --
- yang xu
- Auditors
- --
- lixuan zhao
- Employee Representative Supervisor
- --
- ming yang
- Auditors
- --
- minmin qin
- Chief Technology Officer
- --
- lei fang
- VP
- --
- yunyi li
- Chief Financial Officer, Joint Company Secretary, Board Secretary
- --
- shaojuan li
- Joint Company Secretary, Authorized Representative
- --
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data